MicroRNA-196a2 Biomarker and Targetome Network Analysis in Solid Tumors

Area of Science:

• Genetics
• Molecular Biology
• Oncology

Background:

• MicroRNAs (miRNAs) play a role in cancer development and progression.
• The genetic associations of miRNA single nucleotide polymorphisms (SNPs) with cancer are cancer-site specific.
• Limited research exists on the miR-196a2 variant and its expression in various cancers.

Purpose of the Study:

• To determine the expression profile of mature miR-196a2 in diverse solid tumors.
• To analyze the impact of the miR-196a2 polymorphism (rs11614913; C/T) on its expression levels.
• To investigate the correlation between miR-196a2 expression/polymorphism and clinicopathological features.

Main Methods:

• Real-time polymerase chain reaction (PCR) for miR-196a2 quantification and allelic discrimination.
• Analysis of miRNA expression and SNP identification in cancer patients, pre-cancer lesions, and controls.
• In silico target gene prediction and network analysis.

Main Results:

• The T variant of miR-196a2 (rs11614913) was associated with increased cancer risk across multiple genetic models, notably in colorectal, esophageal, skin, lung, thyroid, and renal cancers.
• miR-196a2 was over-expressed in most malignant tumors compared to normal tissues.
• Carriers of the C allele exhibited significantly higher miR-196a2 expression levels, with organ-specific correlations to clinicopathological features.

Conclusions:

• miR-196a2 exhibits cancer-type specific expression profiles and clinicopathological correlations.
• The study highlights the potential of miR-196a2 as a biomarker for cancer diagnosis and prognosis.